Berivan Baskin

4.4k total citations
47 papers, 2.1k citations indexed

About

Berivan Baskin is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Berivan Baskin has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Genetics and 11 papers in Immunology. Recurrent topics in Berivan Baskin's work include Immunodeficiency and Autoimmune Disorders (9 papers), Muscle Physiology and Disorders (6 papers) and Genomic variations and chromosomal abnormalities (5 papers). Berivan Baskin is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (9 papers), Muscle Physiology and Disorders (6 papers) and Genomic variations and chromosomal abnormalities (5 papers). Berivan Baskin collaborates with scholars based in Canada, Sweden and United States. Berivan Baskin's co-authors include Peter N. Ray, Smith Rjh, Lennart Hammarström, Siew Hwa Ong, Tony Pawson, Leanne Wybenga-Groot, Jiefei Tong, Frank Sicheri, David Malkin and Khalid B. Islam and has published in prestigious journals such as Cell, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Berivan Baskin

46 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berivan Baskin Canada 25 1.1k 470 434 428 221 47 2.1k
Erik J. Uhlmann United States 30 1.7k 1.5× 317 0.7× 383 0.9× 261 0.6× 734 3.3× 73 3.4k
Josiane Grosgeorge France 19 2.0k 1.7× 288 0.6× 315 0.7× 234 0.5× 658 3.0× 32 3.1k
Rakesh Nagarajan United States 30 1.8k 1.6× 417 0.9× 318 0.7× 215 0.5× 332 1.5× 60 3.3k
Lin Pei United States 24 1.3k 1.1× 172 0.4× 296 0.7× 396 0.9× 488 2.2× 48 2.6k
Philip D. Cotter United States 26 1.3k 1.2× 994 2.1× 247 0.6× 153 0.4× 200 0.9× 95 2.4k
Anne Mette Buhl Denmark 21 1.0k 0.9× 127 0.3× 434 1.0× 958 2.2× 329 1.5× 31 2.1k
Michael I. Dorrell United States 25 1.7k 1.5× 107 0.2× 176 0.4× 238 0.6× 192 0.9× 32 2.9k
Wiesława Grajkowska Poland 27 1.9k 1.7× 258 0.5× 1.0k 2.4× 258 0.6× 406 1.8× 174 3.3k
Fengju Chen United States 26 1.6k 1.4× 176 0.4× 278 0.6× 501 1.2× 680 3.1× 62 3.1k
Sung Choe United States 20 1.1k 1.0× 140 0.3× 183 0.4× 157 0.4× 243 1.1× 48 1.8k

Countries citing papers authored by Berivan Baskin

Since Specialization
Citations

This map shows the geographic impact of Berivan Baskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berivan Baskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berivan Baskin more than expected).

Fields of papers citing papers by Berivan Baskin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berivan Baskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berivan Baskin. The network helps show where Berivan Baskin may publish in the future.

Co-authorship network of co-authors of Berivan Baskin

This figure shows the co-authorship network connecting the top 25 collaborators of Berivan Baskin. A scholar is included among the top collaborators of Berivan Baskin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berivan Baskin. Berivan Baskin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinard, Maxime, Constance Smith‐Hicks, Trevor L. Hoffman, et al.. (2021). De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathy. The American Journal of Human Genetics. 108(1). 186–193. 16 indexed citations
2.
Okur, Volkan, Megan T. Cho, Lindsay B. Henderson, et al.. (2016). De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features. Human Genetics. 135(7). 699–705. 53 indexed citations
3.
Steele, Leslie, Johanna M. Rommens, Tracy Stockley, Berivan Baskin, & Peter N. Ray. (2014). De Novo Mutations Causing Shwachman-Diamond Syndrome and a Founder Mutation in SBDS in the French Canadian Population. 1(2). 3 indexed citations
4.
Baskin, Berivan, Dimitri J. Stavropoulos, Martin Li, et al.. (2014). Complex genomic rearrangements in the dystrophin gene due to replication‐based mechanisms. Molecular Genetics & Genomic Medicine. 2(6). 539–547. 17 indexed citations
5.
Molinski, Steven V., Tanja Gonska, Ling Jun Huan, et al.. (2014). Genetic, cell biological, and clinical interrogation of theCFTR mutation c.3700 A>G (p.Ile1234Val) informs strategies for future medical intervention. Genetics in Medicine. 16(8). 625–632. 29 indexed citations
6.
Baskin, Berivan, Sanaa Choufani, Yi‐An Chen, et al.. (2013). High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beckwith–Wiedemann syndrome. Human Genetics. 133(3). 321–330. 58 indexed citations
7.
Yoon, Grace, Berivan Baskin, Mark A. Tarnopolsky, et al.. (2013). Autosomal recessive hereditary spastic paraplegia—clinical and genetic characteristics of a well-defined cohort. Neurogenetics. 14(3-4). 181–188. 26 indexed citations
8.
Baskin, Berivan, Jonathan R. Skinner, Shubhayan Sanatani, et al.. (2013). TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations. Human Genetics. 132(11). 1245–1252. 39 indexed citations
9.
Walker, Erin J., Cindy Zhang, Pedro Castelo‐Branco, et al.. (2011). Monoallelic Expression Determines Oncogenic Progression and Outcome in Benign and Malignant Brain Tumors. Cancer Research. 72(3). 636–644. 42 indexed citations
10.
Al-Zaidy, Samiah, Berivan Baskin, Cynthia Hawkins, et al.. (2011). Milder phenotype of congenital muscular dystrophy in a novel POMT1 mutation. Muscle & Nerve. 45(5). 752–755. 6 indexed citations
11.
Pašić, Ivan, Adam Shlien, Adam D. Durbin, et al.. (2010). Recurrent Focal Copy-Number Changes and Loss of Heterozygosity Implicate Two Noncoding RNAs and One Tumor Suppressor Gene at Chromosome 3q13.31 in Osteosarcoma. Cancer Research. 70(1). 160–171. 126 indexed citations
12.
Baskin, Berivan, William T. Gibson, & Peter N. Ray. (2010). Duchenne muscular dystrophy caused by a complex rearrangement between intron 43 of the DMD gene and chromosome 4. Neuromuscular Disorders. 21(3). 178–182. 18 indexed citations
13.
Baskin, Berivan, Michael T. Geraghty, & Peter N. Ray. (2010). Paternal isodisomy of chromosome 2 as a cause of long chain 3‐hydroxyacyl‐CoA dehydrogenase (LCHAD) deficiency. American Journal of Medical Genetics Part A. 152A(7). 1808–1811. 12 indexed citations
14.
Yano, Shoji, Berivan Baskin, Abdolreza Bagheri, et al.. (2010). Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations. Clinical Genetics. 80(5). 466–471. 25 indexed citations
15.
Shlien, Adam, Berivan Baskin, Maria Isabel Achatz, et al.. (2010). A Common Molecular Mechanism Underlies Two Phenotypically Distinct 17p13.1 Microdeletion Syndromes. The American Journal of Human Genetics. 87(5). 631–642. 25 indexed citations
16.
Moore, S. Jo, H. Dawn Marshall, Leslie Steele, et al.. (2008). The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clinical Genetics. 74(3). 213–222. 51 indexed citations
17.
Wybenga-Groot, Leanne, Berivan Baskin, Siew Hwa Ong, et al.. (2001). Structural Basis for Autoinhibition of the EphB2 Receptor Tyrosine Kinase by the Unphosphorylated Juxtamembrane Region. Cell. 106(6). 745–757. 262 indexed citations
18.
Klominek, Julius, Berivan Baskin, & Dan Hauzenberger. (1998). Platelet-derived growth factor (PDGF) BB acts as achemoattractant for human malignant mesotheliomacells via PDGF receptor b - integrin a3b1 interaction. Clinical & Experimental Metastasis. 16(6). 529–539. 35 indexed citations
19.
Klominek, Julius, Berivan Baskin, Zhiwen Liu, & Dan Hauzenberger. (1998). Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor. International Journal of Cancer. 76(2). 240–249. 60 indexed citations
20.
Rjh, Smith, Khalid B. Islam, Igor Vořechovský, et al.. (1994). X‐Linked Agammaglobulinemia and Other Immunoglobulin Deficiencies. Immunological Reviews. 138(1). 159–183. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik J. Uhlmann Breakdown of academic impact, for papers by Josiane Grosgeorge Breakdown of academic impact, for papers by Rakesh Nagarajan Breakdown of academic impact, for papers by Lin Pei Breakdown of academic impact, for papers by Philip D. Cotter Breakdown of academic impact, for papers by Anne Mette Buhl Breakdown of academic impact, for papers by Michael I. Dorrell Breakdown of academic impact, for papers by Wiesława Grajkowska Breakdown of academic impact, for papers by Fengju Chen Breakdown of academic impact, for papers by Sung Choe
Rankless by CCL
2026